Ranibizumab

ATC CODE

  • S01LA04

INDICATION

  • Sub-retinal neovascular membranes and non-resolving macular odema.

NEMLC RECOMMENDATION

  • Not Approved
    Bevacizumab to be agent for this indication

REVIEW INDICATORS

  • None

DATE RATIFIED

  • 10 December 2015